600
Participants
Start Date
January 10, 2024
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2027
IMC-R117C
IV infusion
Chemotherapy drug
IV infusion
Chemotherapy drug
oral
Kinase inhibitor
oral
Antiangiogenic Agent
IV infusion
Monoclonal antibody
IV infusion
RECRUITING
Institut Jules Bordet, Anderlecht
RECRUITING
UZ Leuven, Leuven
RECRUITING
nstituto Clinico Humanitas, Rozzano
RECRUITING
Peter MacCallum Cancer Centre, Melbourne
RECRUITING
Universitair Ziekenhuis Gent, Ghent
RECRUITING
Universitaetsklinikum Heidelberg, Heidelberg
RECRUITING
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
RECRUITING
Antoni van Leeuwenhoek, Amsterdam
RECRUITING
Hospital HM Nou Delfos, Barcelona
RECRUITING
VHIO, Vall d'Hebron University Hospital, Barcelona
RECRUITING
Centro Integral Oncologico Clara Campal, Madrid
RECRUITING
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Lead Sponsor
Immunocore Ltd
INDUSTRY